+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis



Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis



Discovery Medicine 21(114): 81-88



The highly concentrated lactate in peritoneal dialysis fluid (PDF) has been considered to contribute to peritoneal failure in patients undergoing PD. A new PDF containing a lower lactate concentration, physiological bicarbonate concentration, and neutral pH (bicarbonate/lactate-buffered neutral PDF) was recently developed. We compared the clinical effects of this bicarbonate/lactate-buffered neutral PDF and a lactate-buffered neutral PDF. Patients undergoing PD were changed from a lactate-buffered neutral PDF to a bicarbonate/lactate-buffered neutral PDF. We then investigated the changes in peritoneal functions as estimated by a peritoneal equilibration test (PET) and the following surrogate markers of peritoneal membrane failure in the drained dialysate: fibrin degradation products (FDP), vascular endothelial growth factor (VEGF), cancer antigen 125 (CA125), interleukin-6 (IL-6), and transforming growth factor beta 1 (TGF-β1). Fourteen patients undergoing PD were enrolled. The PET results were not different before and after use of the bicarbonate/lactate-buffered neutral PDF. The FDP concentration significantly decreased from 15.60 ± 13.90 to 6.04 ± 3.49 μg/mL (p = 0.02) and the VEGF concentration significantly decreased from 37.83 ± 15.82 to 27.70 ± 3.80 pg/mL (p = 0.02), while the CA125 and IL-6 concentrations remained unchanged before and after use of the bicarbonate/lactate-buffered neutral PDF. TGF-β1 was not detected in most patients. The bicarbonate/lactate-buffered neutral PDF decreased the FDP and VEGF concentrations in the drained dialysate. These results suggest that the decreased lactate level achieved by administration of bicarbonate with a neutral pH in PDF may contribute to decreased peritoneal membrane failure in patients undergoing PD.

(PDF emailed within 1 workday: $29.90)

Accession: 057723765

Download citation: RISBibTeXText

PMID: 27011043


Related references

Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis. Therapeutic Apheresis and Dialysis 22(6): 641-648, 2018

Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions. Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 187-191, 2006

Bicarbonate/lactate-buffered peritoneal dialysis fluid decreases pro-collagen I levels in peritoneal dialysis effluent. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 264A, Sept, 1997

In vivo exposure to bicarbonate/lactate-buffered peritoneal dialysis fluid decreases pro-collagen I and TGF-beta1 levels in peritoneal dialysis effluent. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 290A, Sept, 1998

Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients. Therapeutic Apheresis and Dialysis 20(2): 149-157, 2017

Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Peritoneal Dialysis International 28(1): 44-52, 2008

Acute effects of bicarbonate buffered neutral dialysis solutions on peritoneal mass transport during rat peritoneal dialysis. Journal of the American Society of Nephrology 7(9): 1425, 1996

Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. Journal of the American Society of Nephrology 13 Suppl 1: S97-103, 2002

Comparison of a lactate and a bicarbonate/lactate buffered peritoneal dialysis solution in a rat model of continuous peritoneal dialysis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 209A, 2000

Monocarboxylate Transporter-1 Mediates the Protective Effects of Neutral-pH Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluid on Cell Viability and Apoptosis. Therapeutic Apheresis and Dialysis 21(1): 62-70, 2016

In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function. American Journal of Kidney Diseases 26(6): 924-933, 1995

Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clinical and Experimental Nephrology 8(4): 339-343, 2004

In vivo exposure to bicarbonate/lactate and bicarbonate buffered peritoneal dialysis fluids improves peritoneal macrophage function. Journal of the American Society of Nephrology 7(9): 1431, 1996

Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion. Journal of the American Society of Nephrology 9(8): 1499-1506, 1998

Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture. Peritoneal Dialysis International 26(3): 353-359, 2006